Association between quality management and performance indicators in Dutch diabetes care groups: a cross-sectional study

• Published in: BMJ open 2015-05, Vol.5 (5), p.e007456-e007456
• Main Authors: Campmans-Kuijpers, Marjo J E, Baan, Caroline A, Lemmens, Lidwien C, Klomp, Maarten L H, Romeijnders, Arnold C M, Rutten, Guy E H M
• Format: Article
• Language: English
• Subjects: Blood Glucose - metabolism; Blood Pressure; Business metrics; Cholesterol, LDL - blood; Clinical outcomes; Cross-Sectional Studies; Delivery of Health Care - organization & administration; Delivery of Health Care - standards; Diabetes; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - therapy; Disease Management; General practice / Family practice; Glycated Hemoglobin A - metabolism; Group medical practice; Humans; Netherlands; Quality Improvement; Quality Indicators, Health Care; Quality management; Questionnaires; Registration; Studies; Surveys and Questionnaires; Validity
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2014-007456

ObjectivesTo enhance the quality of diabetes care in the Netherlands, so-called care groups with three to 250 general practitioners emerged to organise and coordinate diabetes care. This introduced a new quality management level in addition to the quality management of separate general practices. We hypothesised that this new level of quality management might be associated with the aggregate performance indicators on the patient level. Therefore, we aimed to explore the association between quality management at the care group level and its aggregate performance indicators.DesignA cross-sectional study.SettingAll Dutch care groups (n=97).Participants23 care groups provided aggregate register-based performance indicators of all their practices as well as data on quality management measured with a questionnaire filled out by 1 or 2 of their quality managers.Primary outcomesThe association between quality management, overall and in 6 domains (‘organisation of care’, ‘multidisciplinary teamwork’, ‘patient centredness’, ‘performance management’, ‘quality improvement policy’ and ‘management strategies’) on the one hand and 3 process indicators (the percentages of patients with at least 1 measurement of glycated haemoglobin, lipid profile and systolic blood pressure), and 3 intermediate outcome indicators (the percentages of patients with glycated haemoglobin below 53 mmol/mol (7%); low-density lipoprotein cholesterol below 2.5 mmol/L; and systolic blood pressure below 140 mm Hg) by weighted univariable linear regression.ResultsThe domain ‘management strategies’ was significantly associated with the percentage of patients with a glycated haemoglobin